amsacrine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 10 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bortezomib, a proteasome inhibitor, has been used for patients with refractory and relapsed multiple myeloma, lymphoma and leukemia." | 3.74 | The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients. ( Jin, J; Li, Y; Meng, H; Qian, J; Tong, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tong, Y | 1 |
| Qian, J | 1 |
| Li, Y | 1 |
| Meng, H | 1 |
| Jin, J | 1 |
| McLaughlin, P | 1 |
| Salvador, PG | 1 |
| Cabanillas, F | 1 |
| Legha, SS | 1 |
| Hutter, JJ | 1 |
| Meyskens, FL | 1 |
| Cheng, AL | 1 |
| Damiani, D | 1 |
| Grimaz, S | 1 |
| Infanti, L | 1 |
| Sperotto, A | 1 |
| Silvestri, F | 1 |
| Geromin, A | 1 |
| Cerno, M | 1 |
| Savignano, C | 1 |
| Michieli, M | 1 |
| Skert, C | 1 |
| Fanin, R | 1 |
| Baccarani, M | 1 |
| Dreyfus, F | 1 |
| Leblond, V | 1 |
| Belanger, C | 1 |
| Gabarre, J | 1 |
| Sutton, L | 1 |
| Boccaccio, C | 1 |
| Quarre, MC | 1 |
| Ribrag, V | 1 |
| Goy, A | 1 |
| Willemze, R | 3 |
| Peters, WG | 3 |
| Colly, LP | 1 |
| Tham, RT | 1 |
| de Bruïne, FT | 1 |
| Rybak, ME | 1 |
| Anderson, JR | 1 |
| Poulin, RF | 1 |
| Amrein, PC | 1 |
| Canellos, GP | 1 |
| Gottlieb, AJ | 1 |
| van Hennik, MB | 1 |
| Fibbe, WE | 1 |
| Kootte, AM | 1 |
| van Berkel, M | 1 |
| Lie, R | 1 |
| Rodenburg, CJ | 1 |
| Veltkamp, JJ | 1 |
1 trial available for amsacrine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Phase II trial of m-AMSA therapy in refractory Hodgkin's disease and non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 7972.
Topics: Aged; Amsacrine; Clinical Trials as Topic; Drug Evaluation; Female; Hematologic Diseases; Hodgkin Di | 1986 |
9 other studies available for amsacrine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients.
Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boron | 2007 |
Ventricular fibrillation following AMSA. Uncomplicated retreatment following correction of hypokalemia.
Topics: Adult; Aminoacridines; Amsacrine; Antineoplastic Agents; Female; Humans; Hypocalcemia; Lymphoma, Non | 1983 |
AMSA therapy for children with lymphoblastic malignancy.
Topics: Adolescent; Aminoacridines; Amsacrine; Antineoplastic Agents; Child; Child, Preschool; Humans; Leuke | 1982 |
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cyclophosphamide; Cyta | 1996 |
Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recovery.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmu | 1999 |
Peripheral blood stem cell collection and autografting in high risk lymphomas.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Blood Tra | 1992 |
Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHL.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Lymphoid; L | 1987 |
Pulmonary complications of cytosine-arabinoside therapy: radiographic findings.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, | 1987 |
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytara | 1985 |